A number of proinflammatory molecules [e.g., tumor necrosis factor-alpha (TNF-α), interleukin-1beta (IL-1β), and interleukin-6 (IL-6)] are expressed at high levels in the development of IBD (Hart et al., 2005; Brand et al., 2006). This evidence concerns the gene IL1B and inflammatory bowel disease.